Search Page

1

Cite

Share

Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.

Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM, Firn JI, Paice JA, Peppercorn JM, Phillips T, Stovall EL, Zimmermann C, Smith TJ. Ferrell BR, et al. Among authors: basch em. J Clin Oncol. 2017 Jan;35(1):96-112. doi: 10.1200/JCO.2016.70.1474. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28034065 Review.

Cite

Share

2

Cite

Share

Patient-Reported Outcomes in Cancer Clinical Trials: Measuring Symptomatic Adverse Events With the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).

Kluetz PG, Chingos DT, Basch EM, Mitchell SA. Kluetz PG, et al. Among authors: basch em. Am Soc Clin Oncol Educ Book. 2016;35:67-73. doi: 10.1200/EDBK_159514. Am Soc Clin Oncol Educ Book. 2016. PMID: 27249687 Free article. Review.

Cite

Share

3

Cite

Share

Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy.

Leahy AB, Schwartz LA, Li Y, Reeve BB, Bekelman JE, Aplenc R, Basch EM. Leahy AB, et al. Among authors: basch em. Cancer. 2021 Aug 15;127(16):2980-2989. doi: 10.1002/cncr.33617. Epub 2021 May 4. Cancer. 2021. PMID: 33945640 Free PMC article.

Cite

Share

4

Cite

Share

Electronic toxicity monitoring and patient-reported outcomes.

Basch EM, Reeve BB, Mitchell SA, Clauser SB, Minasian L, Sit L, Chilukuri R, Baumgartner P, Rogak L, Blauel E, Abernethy AP, Bruner D. Basch EM, et al. Cancer J. 2011 Jul-Aug;17(4):231-4. doi: 10.1097/PPO.0b013e31822c28b3. Cancer J. 2011. PMID: 21799330 Free PMC article. Review.

Cite

Share

5

Cite

Share

Strategies to Achieve High-Value Oncology Care-A Beginning.

Sox HC, Basch EM, Berwick D. Sox HC, et al. Among authors: basch em. JAMA Oncol. 2018 Feb 1;4(2):171-172. doi: 10.1001/jamaoncol.2017.3794. JAMA Oncol. 2018. PMID: 29145560 No abstract available.

Cite

Share

6

Cite

Share

Stakeholder Perceptions of Key Aspects of High-Quality Cancer Care to Assess with Patient Reported Outcome Measures: A Systematic Review.

Stover AM, Kurtzman R, Walker Bissram J, Jansen J, Carr P, Atkinson T, Ellis CT, Freeman AT, Turner K, Basch EM. Stover AM, et al. Among authors: basch em. Cancers (Basel). 2021 Jul 20;13(14):3628. doi: 10.3390/cancers13143628. Cancers (Basel). 2021. PMID: 34298841 Free PMC article. Review.

Cite

Share

7

Cite

Share

The Potential Role of Symptom Questionnaires in Palliative and Supportive Cancer Care Delivery.

Stover AM, Basch EM. Stover AM, et al. Among authors: basch em. Curr Oncol Rep. 2017 Feb;19(2):12. doi: 10.1007/s11912-017-0571-z. Curr Oncol Rep. 2017. PMID: 28220450 Free PMC article. Review.

Cite

Share

8

Cite

Share

A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.

Kim SI, Szeto AH, Morgan KP, Brower B, Dunn MW, Khandani AH, Godley PA, Rose TL, Basch EM, Milowsky MI, Whang YE, Crona DJ. Kim SI, et al. Among authors: basch em. PLoS One. 2021 Jun 21;16(6):e0253021. doi: 10.1371/journal.pone.0253021. eCollection 2021. PLoS One. 2021. PMID: 34153052 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Implementation of Symptom Questionnaires Into Oncology Workflow.

Stover AM, Basch EM. Stover AM, et al. Among authors: basch em. J Oncol Pract. 2016 Oct;12(10):859-862. doi: 10.1200/JOP.2016.015610. J Oncol Pract. 2016. PMID: 27601508 Free PMC article. No abstract available.

Cite

Share

10

Cite

Share

Monitoring the clinical outcomes in advanced prostate cancer: what imaging modalities and other markers are reliable?

Morris MJ, Autio KA, Basch EM, Danila DC, Larson S, Scher HI. Morris MJ, et al. Among authors: basch em. Semin Oncol. 2013 Jun;40(3):375-92. doi: 10.1053/j.seminoncol.2013.04.008. Semin Oncol. 2013. PMID: 23806501 Review.

Cite

Share